We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

8252:TSEMarui Group Co., Ltd. Analysis

Data as of 2026-03-15 - not real-time

¥3,084.00

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Marui Group trades at ¥3,084, sitting just above the identified support of ¥3,049 and below the 20‑day and 50‑day SMAs (~¥3,136), indicating a short‑term price ceiling. The RSI of 45 suggests neutral momentum, while the MACD is firmly bearish (negative line and histogram), flagging downward pressure despite the overall bullish trend label. Volume is on an increasing trend, providing liquidity for moves toward the near‑term resistance at ¥3,212. Volatility is elevated at ~19.8% over the past 30 days, but the beta of 0.08 points to minimal market‑wide risk. Fundamentally, the stock appears stretched with a P/E of 19.2 versus the industry average of 16.4 and a payout ratio of 73% on a dividend yield of 4.28%, raising concerns about sustainability given negative operating cash flow (‑¥4.7 bn) and free cash flow (‑¥9.9 bn). The balance sheet is heavily leveraged, reflected in a debt‑to‑equity of 325 and total debt exceeding ¥770 bn, far surpassing the market cap of ¥554 bn. Revenue growth remains healthy at 8.7%, and operating margins sit at 19.3%, but profit margins are reported as zero, underscoring earnings volatility. In sum, the stock offers an attractive yield but is burdened by high leverage, cash‑flow deficits, and a valuation premium, suggesting caution for investors.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price near support level of ¥3,049
  • Bearish MACD histogram
  • Increasing volume providing short‑term liquidity

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Solid revenue growth of 8.7%
  • High dividend yield of 4.28% with 73% payout
  • Elevated leverage and negative cash flow

Long Term

> 3 years
Cautious
Model confidence: 7/10

Key Factors

  • Debt‑to‑equity ratio above 300, indicating financial strain
  • Overvalued relative to industry P/E
  • Unsustainable dividend given cash‑flow deficits

Key Metrics & Analysis

Financial Health

Revenue Growth8.70%
P/E Ratio19.2
Debt/Equity324.81
P/B Ratio2.3
Op. Cash Flow¥-4720999936
Free Cash Flow¥-9868375040
Industry P/E16.4

Technical Analysis

TrendBullish
RSI45.0
Support¥3,049.00
Resistance¥3,212.00
MA 20¥3,136.45
MA 50¥3,135.70
MA 200¥3,111.79
MACDBearish
VolumeIncreasing
Fear & Greed Index72.88

Valuation

Target Price¥3,533.33
Upside/Downside14.57%
GradeOvervalued
TypeBlend
Dividend Yield4.28%

Risk Assessment

Beta0.08
Volatility19.83%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.